Quick Links: Skip to main page content Skip to Search Skip to Topics Menu Skip to Common Links
  • Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Class 2 Device Recall LIFECODES PF4 Enhanced assay

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 


New Search Back to Search Results
 Class 2 Device Recall LIFECODES PF4 Enhanced assaysee related information
Date Initiated by FirmFebruary 04, 2013
Date PostedMarch 28, 2013
Recall Status1 Terminated 3 on March 21, 2016
Recall NumberZ-1022-2013
Recall Event ID 64501
510(K)NumberK053559 
Product Classification Platelet factor 4 radioimmunoassay - Product Code LCO
ProductGen-Probe LIFECODES PF4 Enhanced assay, Catalog No. X-HAT45 GTI PF4 Enhanced is designed as a solid phase enzyme-linked immunosorbent assay (ELISA).
Code Information Kit Lot Number 3000389
FEI Number 2183608
Recalling Firm/
Manufacturer		 Genetic Testing Institute,inc
20925 Crossroads Cir Ste 200
Waukesha WI 53186-4054
For Additional Information Contact
262-754-1000
Manufacturer Reason
for Recall		Lifecodes PF4 Enhanced assay, lot number 3000389, is being recalled because of observed inconsistent replicate values when testing the kit Positive Control and patient samples. The variation in reactivity can lead to invalid assays. If an invalid assay is obtained, those results should not be reported and the test should be re-run. An invalid assay would not result in significant harm to a pati
FDA Determined
Cause 2		Process control
ActionHologic/Gen-Probe sent an Urgent Medical Device Recall letter dated February 4, 2013, via FedEx overnight deliver yto all affected customers. The letter identified affected product, stated the issue, and asked that product from the affected lot stop being used. Reported results for all samples tested using the affected lot should be reviewed. The referring physician should be notified that any negative patient result may be erroneous. Remaining inventory should be returned to Gen-Probe. A response form was also asked to be returned. For questions customers were instructed to contact Technical Support at 262-754-1000 or waukeshatechsupport@gen-probe.com. For questions regarding this recall call 262-754-1026.
Quantity in Commerce386 kits (370 US, 16 OUS)
DistributionWorldwide Distribution - USA (nationwide) and Internationally to Canada, China, Slovakia, and Spain.
Total Product Life CycleTPLC Device Report
1 A record in this database is created when a firm initiates a correction or removal action. The record is updated if the FDA identifies a violation and classifies the action as a recall, and it is updated for a final time when the recall is terminated. Learn more about medical device recalls.
2 Per FDA policy, recall cause determinations are subject to modification up to the point of termination of the recall.
3 For details about termination of a recall see Code of Federal Regulations (CFR) Title 21 §7.55.
510(K) Database510(K)s with Product Code = LCO
-
-